CCN2 and colon carcinoma: Some SNPs in CCN2 have been associated with an increased risk of developing several human pathologies, mainly related to fibrotic disorders, including systemic sclerosis [19], pulmonary fibrosis [18], colon carcinoma [16], diabetic nephropathy [17] and hepatic fibrosis [15].